LASSA FEVER
Clinical trials for LASSA FEVER explained in plain language.
Never miss a new study
Get alerted when new LASSA FEVER trials appear
Sign up with your email to follow new studies for LASSA FEVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New oral drug shows promise against deadly lassa fever
Disease control Recruiting nowThis study tests a new oral antiviral drug, ARN-75039, for treating Lassa fever in hospitalized adults in West Africa. About 135 participants will receive either a high or low dose of the new drug or the standard IV treatment, ribavirin, for 10 days. The goal is to see if the new…
Matched conditions: LASSA FEVER
Phase: PHASE2 • Sponsor: Arisan Therapeutics, Inc. • Aim: Disease control
Last updated Apr 24, 2026 04:59 UTC
-
Race for a better treatment against deadly lassa fever
Disease control Recruiting nowThis large international trial aims to find better drugs to treat people hospitalized with Lassa fever, a serious and often fatal viral disease in West Africa. It will test several new and repurposed medications against the current standard treatment, ribavirin, to see which ones…
Matched conditions: LASSA FEVER
Phase: PHASE2, PHASE3 • Sponsor: Irrua Specialist Teaching Hospital • Aim: Disease control
Last updated Apr 14, 2026 13:09 UTC